Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 29, Issue 1, 2011, Pages 93-95

  Scioscia, Crescenzio ^a   Scioscia, Marco ^b,c   Anelli, Maria ^a   Praino, Emanuela ^a   Bettocchi, Stefano ^a   Lapadula, Giovanni ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Sacro Cuore Don Calabria Hospital   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Clinical outcome; Disease activity; Pregnancy; Puerperium; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; ETANERCEPT; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; FETUS GROWTH; FOLLOW UP; HUMAN; LACTATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PUERPERIUM; REMISSION; RHEUMATOID ARTHRITIS; RISK FACTOR; SCORING SYSTEM; DRUG EFFECT; HEALTH STATUS; HOSPITALIZATION; LIVE BIRTH; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HEALTH STATUS; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; LACTATION; LIVE BIRTH; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, TUMOR NECROSIS FACTOR; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 79955649180     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
2. BARRETT JH, BRENNAN P, FIDDLER M et al.: Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. Arthritis Rheum 2000; 43: 1010-5.
3. NELSON JL, OSTENSEN M: Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am 1997; 23: 195-212.
4. NELSON JL: Pregnancy immunology and autoimmune disease. J Reprod Med 1998; 43: 335-40.
5. LIN HC, CHEN SF, LIN HC et al.: Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population-based study. Ann Rheum Dis 2010; 69: 715-7.
6. MCINNES IB, SCHETT G: Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 7: 429-42.
7. REDMAN CW, SARGENT IL: Preeclampsia and the systemic inflammatory response. Semin Nephrol 2004; 24: 565-70.
8. SARGENT IL, BORZYCHOWSKI AM, REDMAN CW: NK cells and human pregnancy--an inflammatory view. Trends Immunol 2006; 27: 399-404.
9. GAUIOUX-VIALA C, EVMARD C, DOUGADOS M et al.: Pregnancy appears difficult to obtain and TNF-alpha blockers cannot always be discontinued in women with rheumatic diseases. Clin Exp Rheumatol 2009; 27: 1059.
10. ALI YM, KURIYA B, OROZCO C et al.: Can tumor necrosis factor inhibitors be safely used in pregnancy? J Rheumatol 2010; 37: 9-17.
11. SINHA A, PATIENT C: Rheumatoid arthritis in pregnancy: successful outcome with anti-TNF agent (Etanercept). J Obstet Gynaecol 2006; 26: 689-91.
12. UMEDA N, ITO S, HAYASHI T et al.: A patient with rheumatoid arthritis who had a normaldelivery under etanercept treatment. Intern Med 2010; 49: 187-9.
13. BERTHELOT JM, DE BM, GOUPILLE P et al.: Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature. Joint Bone Spine 2009; 76: 28-34.
14. CARTER JD, VALERIANO J, VASEY FB: Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship. J Rheumatol 2006; 33: 1014-7.
15. CARTER JD, LADHANI A, RICCA LR et al.: A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol 2009; 36: 635-41.
16. DE MAN YA, HAZES JM,VAN DE GEIJN FE et al.: Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis. Arthritis Rheum 2007; 57: 716-22.
17. DE MAN YA, HAZES JM, VAN DER HH et al.: Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum 2009; 60: 3196-206.
18. ROUX CH, BROCQ O, BREUIL V et al.: Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford) 2007; 46: 695-8.